Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3-(2-dimethylamino)ethyl)indol-4-ol
2. Psilocin Hydrochloride
3. Psilocin Tartrate (1:1)
1. Psilocine
2. 4-hydroxy-n,n-dimethyltryptamine
3. 520-53-6
4. Psilotsin
5. Psilocyn
6. 3-[2-(dimethylamino)ethyl]-1h-indol-4-ol
7. 3-(2-(dimethylamino)ethyl)indol-4-ol
8. N,n-dimethyl-4-hydroxytryptamine
9. 3-(2-(dimethylamino)ethyl)-1h-indol-4-ol
10. Cms88kuw0g
11. 4-ho-dmt
12. Chembl65547
13. Chebi:8613
14. Ncgc00247728-01
15. 1h-indol-4-ol, 3-[2-(dimethylamino)ethyl]-
16. 3-[2-(dimethylamino)ethyl]-1~{h}-indol-4-ol
17. Indol-4-ol, 3-(2-(dimethylamino)ethyl)-
18. Indol-4-ol, 3-[2-(dimethylamino)ethyl]-
19. Cx-59
20. Einecs 208-296-5
21. Unii-cms88kuw0g
22. Brn 0160503
23. Dea No. 7438
24. 91q
25. Psilocin [mi]
26. Psilocin [mart.]
27. Psilocin [who-dd]
28. 4-oh-dmt
29. Magic Mushrooms (salt/mix)
30. Dsstox_cid_28825
31. Dsstox_rid_83094
32. Dsstox_gsid_48899
33. 5-22-12-00014 (beilstein Handbook Reference)
34. Schembl194899
35. Psilocin/psilocybin (salt/mix)
36. Zinc2001
37. Dtxsid5048899
38. Gtpl11291
39. Spciygntamctro-uhfffaoysa-
40. Cx 59
41. Tox21_112894
42. Bdbm50081701
43. Akos022505992
44. En-0002
45. 3-[2-(dimethylamino)ethyl]-indol-4-ol
46. Cas-520-53-6
47. 3-[2-(dimethylamino)ethyl]-1h-indol-4-ol #
48. C08312
49. P-7800
50. 4-hydroxy-n,n-dimethyltryptamine Psilocin
51. L000675
52. Q409150
53. Psilocin, Vial Of 5 Mg, Certified Reference Material
54. Psilocin Solution, 100 Mug/ml In Methanol, Drug Standard
55. Psilocin Solution, 1.0 Mg/ml In Acetonitrile, Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 204.27 g/mol |
---|---|
Molecular Formula | C12H16N2O |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 204.126263138 g/mol |
Monoisotopic Mass | 204.126263138 g/mol |
Topological Polar Surface Area | 39.3 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hallucinogens
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)
Psilocin has known human metabolites that include (2S,3S,4S,5R)-6-[[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?